Sign in
4

Changes in Ownership

Cocrystal Pharma, Inc. Filed Acc 0001415889-14-003810

Options or other derivatives

  • Director acquired 5,919,681 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Schinazi Raymond F Director 2014-11-25 Grant or award · Series A Convertible Preferred Stock +798,747 798,747 D
Schinazi Raymond F Director 2014-11-25 Grant or award · Stock Options (Right to Buy) +1,706,978 1,706,978 D
Schinazi Raymond F Director 2014-11-25 Grant or award · Stock Options (Right to Buy) +1,706,978 1,706,978 D
Schinazi Raymond F Director 2014-11-25 Grant or award · Stock Options (Right to Buy) +1,706,978 1,706,978 D
Loading xslF345X03/form4-12052014_011258.xml…